A novel methionine nanoparticle in broiler chickens: Bioavailability and requirements.

This bioassay evaluated the bioavailability (RBV) of a novel nanoparticle of methionine (nano-Met) relative to DL-methionine (DL-Met), and estimated methionine requirements for both sources in starting broilers. Five supplemental levels (0.05, 0.10, 0.15, 0.20, and 0.25% of diet) of DL-Met or nano-Met were added to a basal diet containing 0.35% standardized ileal digestible (SID) methionine to create 11 experimental diets, including a basal diet and 10 experimental diets containing 0.40, 0.45, 0.50, 0.55, and 0.60% SID-Met, respectively. A total of 825 one-day-old male Ross 308 birds were randomly assigned to 11 treatments with 5 pen replicates and 15 birds each. Body weight gain (BWG), breast meat yield (BMY), and thigh meat yield (TMY) increased (P < 0.001) while feed conversion ratio (FCR) and malondialdehyde (MDA) concentration in meat samples decreased (P < 0.001) with increasing dietary methionine. Based on the slope-ratio method, the RBV of nano-Met relative to DL-Met for BWG, FCR, and TMY were 102 (48-155%; R2 = 0.71), 134 (68-201%; R2 = 0.77), and 110% (27-193%; R2 = 0.55), respectively. Considering the statistical accuracy of the spline models, the estimated values of DL-Met for maximum BWG and nano-Met for maximum TMY were 0.578% and 0.561%, respectively, which were statistically higher than those recommended for commercial settings. The highest effect size of supplemental methionine was on MDA (ƞ2p = 0.924), followed by FCR (ƞ2p = 0.578), BMY (ƞ2p = 0.575), BWG (ƞ2p = 0.430), and TMY (ƞ2p = 0.332), suggesting the potent antioxidant properties of methionine. Our findings suggest that reducing the particle size of DL-Met to nanoparticles could be a promising strategy to enhance the efficiency of methionine supplementation in broilers, an idea that requires further investigation in future research.

Response surface model to illustrate the benefits of tryptophan, melatonin, and N,N-dimethylglycine in quail chicks exposed to aflatoxin B1.

A dose-response assay in a central composite design platform was conducted to investigate the responses (performance, immunity, and meat quality) of quail chicks to dietary tryptophan (Trp), melatonin (MEL), and N,N-dimethylglycine (DMG) exposed to aflatoxin B1 (AFB1). A total of 1,275 quail chicks were randomly allotted to 85-floor pens consisting of 17 treatments with 5 replicates and 15 birds per each pen. Dietary MEL and DMG had a different effect on growth rate and interacted with dietary Trp and AFB1 during the first 4 wk of age, while their effect disappeared at the last week of the experiment. Dietary Trp and AFB1 were only significant on the gain of quail chick after d 28 of the assay. During the second and third weeks of age, the reduction in feed intake caused by AFB1 attenuated by dietary MEL and DMG and dietary Trp profoundly affects feed intake in the last 2 wk of the experiment. Dietary MEL and DMG were effective on feed conversion ratio (FCR) during the second and third weeks of age. AFB1 decreased breast meat yield (BMY) and thigh meat yield (TMY), but the inclusion of either MEL or DMG removed the adverse effects of AFB1. Dietary Trp increased BMY, but it did not affect TMY. Increasing dietary Trp linearly increased the Lactobacillus bacteria (LAB) population, and AFB1 negatively impacts the LAB population. The inclusion of dietary DMG removed that negative effect on LAB. Although AFB1 decreased the antibody production against SRBC-antigen, increasing dietary Trp in intoxicated quails increased the plasma antibody in SRBC-challenged birds. At low levels of dietary Trp (0.15-0.19%), the addition of DMG increased malondialdehyde (MDA) production while increasing Trp reversed this adverse situation. In conclusion, these supplements may interact with AFB1 in younger chicks, and dietary Trp and AFB1 have a significant impact on the growth performance of quail chicks during the fifth and sixth week of age.